290650.KQ KOE
L&C Bio Co., Ltd
1W: +13.8%
1M: +3.4%
3M: -40.8%
YTD: -40.5%
1Y: +58.2%
3Y: +52.8%
5Y: +62.0%
₩53,700.00 ($39.74)
-2600.00 (-4.62%)
Weekly Expected Move ±10.6%
₩42317
₩48009
₩53700
₩59391
₩65083
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$12.6B
+246.7% ▲
5Y CAGR: +11.1%
Capital Expenditures
$15.8B
-195.5% ▼
5Y CAGR: +38.9%
Free Cash Flow
-$3.2B
+76.7% ▲
Dividends Paid
$1.1B
+50.5% ▲
Buybacks
$10.0B
+0.0% ▲
Net Change in Cash
$12.6B
+277.6% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $15.6B | $5.7B | $48.5B | $141.0B | -$138.5B |
| Depreciation & Amort. | $2.9B | $4.5B | $5.7B | $6.8B | $8.1B |
| Stock-Based Comp. | $727M | $376M | $139M | $150M | $0 |
| Change in Working Capital | -$7.2B | -$21.4B | -$26.5B | -$2.5B | -$1.6B |
| Other Non-Cash Items | -$81M | $3.3B | -$40.0B | -$154.0B | $144.6B |
| Operating Cash Flow | $10.9B | -$6.1B | -$12.1B | -$8.6B | $12.6B |
| — Investing Activities — | |||||
| Capital Expenditures | -$11.4B | -$37.7B | -$24.5B | -$4.7B | -$17.0B |
| Acquisitions (Net) | $2.6B | -$42.4B | $1.1B | -$22.7B | -$13.0B |
| Investment Purchases | -$18.7B | -$11.3B | $0 | -$27.0B | -$125.0B |
| Investment Sales | $12.4B | $7.9B | $86.1B | $61.3B | $121.9B |
| Other Investing | -$5.4B | -$151M | -$38.0B | -$28.8B | $1.6B |
| Investing Cash Flow | -$20.5B | -$83.6B | $24.6B | -$21.9B | -$31.5B |
| — Financing Activities — | |||||
| Net Debt Issuance | $6.0B | $81.1B | -$1.7B | $36.5B | $26.4B |
| Stock Repurchased | -$2.0B | $0 | -$840M | $0 | -$10.0B |
| Dividends Paid | -$1.1B | -$1.1B | -$1.1B | -$2.3B | -$1.1B |
| Other Financing | $1.8B | -$1.1B | -$524M | -$432M | -$1.8B |
| Financing Cash Flow | $4.7B | $78.9B | -$4.2B | $33.8B | $30.8B |
| Net Change in Cash | -$4.9B | -$10.8B | $8.4B | $3.3B | $12.6B |
| Cash End of Period | $17.4B | $6.6B | $14.9B | $18.3B | $30.9B |
| Free Cash Flow | -$521M | -$43.8B | -$37.1B | -$13.9B | -$3.2B |